Ligation of CD80 is critical for high-level CD25 expression on CD8 + T lymphocytes

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4495-4502

  Pejawar Gaddy, Sharmila ^a   Alexander Miller, Martha A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD28 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; NOTCH RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HISTOGRAM; LISTERIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

EID: 33749147884     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4495     Document Type: Article

References (41)

1. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
4. Curtsinger, J. M., C. M. Johnson, and M. F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171: 5165-5171.
5. L. Immunity 3: 87-98.
6. Noel, P. J., L. H. Boise, and C. B. Thompson. 1996. Regulation of T cell activation by CD28 and CTLA4. In Mechanism of Lymphocyte Activation and Immune Regulation VI: Cell Cycle and Programmed Cell Death in the Immune System. S. Gupta and J. J. Cohen, eds. Plenum, New York, pp. 209-217.
7. Lanier, L. L., S. O'Fallon, C. Somoza, J. H. Phillips, P. S. Linsley, K. Okumura, D. Ito, and M. Azuma. 1995. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 154: 97-105.
8. + TCR-transgenic T cells. J. Immunol. 161: 5268-5275.
9. Matulonis, U., C. Dosiou, G. Freeman, C. Lamont, P. Mauch, L. M. Nadler, and J. D. Griffin. 1996. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity: further evidence that B7-1 and B7-2 are functionally distinct. J. Immunol. 156: 1126-1131.
10. van Dijk, A. M., H. G. Otten, S. M. Vercauteren, F. L. Kessler, M. de Boer, L. F. Verdonck, and G. C. de Gast. 1996. Human B7-1 is more efficient than B7-2 in providing costimulation for alloantigen-specific T cells. Eur. J. Immunol. 26: 2275-2278.
11. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156: 465-472.
12. Sansom, D. M., C. N. Manzotti, and Y. Zheng. 2003. What's the difference between CD80 and CD86? Trends Immunol. 24: 314-319.
13. Lumsden, J. M., J. M. Roberts, N. L. Harris, R. J. Peach, and F. Ronchese. 2000. Differential requirement for CD80 and CD80/CD86-dependent costimulation in the lung immune response to an influenza virus infection. J. Immunol. 164: 79-85.
14. Pejawar, S. S., G. D. Parks, and M. A. Alexander-Miller. 2005. Abortive versus productive viral infection of dendritic cells with a paramyxovirus results in differential up-regulation of select costimulatory molecules. J. Virol. 79: 7544-7557.
15. Lauvau, G., S. Vijh, P. Kong, T. Horng, K. Kerksiek, N. Serbina, R. A. Tuma, and E. G. Pamer. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294: 1735-1739.
16. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
17. He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237: 249-260.
18. Parks, G. D., K. R. Ward, and J. C. Rassa. 2001. Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis. J. Virol. 75: 2213-2223.
19. D'Souza, W. N., and L. Lefrancois. 2003. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171: 5727-5735.
20. Bhatia, S., M. Edidin, S. C. Almo, and S. G. Nathenson. 2005. B7-1 and B7-2: similar costimulatory ligands with different biochemical, oligomeric and signaling properties. Immunol. Lett. 104: 70-75.
21. Bhatia, S., M. Edidin, S. C. Almo, and S. G. Nathenson. 2005. Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc. Natl. Acad. Sci. USA 102: 15569-15574.
22. Slavik, J. M., J. E. Hutchcroft, and B. E. Bierer. 1999. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28. J. Biol. Chem. 274: 3116-3124.
23. Jansson, A., E. Barnes, P. Klenerman, M. Harlen, P. Sorensen, S. J. Davis, and P. Nilsson. 2005. A theoretical framework for quantitative analysis of the molecular basis of costimulalion. J. Immunol. 175: 1575-1585.
24. Masten, B. J., J. L. Yates, A. M. Pollard Koga, and M. F. Lipscomb. 1997. Characterization of accessory molecules in murine lung dendritic cell function: roles for CD80, CD86, CD54, and CD40L. Am. J. Respir. Cell Mol. Biol. 16: 335-342.
25. Gajewski, T. F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol. 156: 2909-2917.
26. +, murine myelogenous leukemia. Blood 99: 2146-2153.
27. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193: 1007-1008.
28. Kaplan, D. R., V. L. Braciale, and T. J. Braciale. 1984. Antigen-dependent regulation of interleukin-2 receptor expression on cloned human cytotoxic T lymphocytes. J. Immunol. 133: 1966-1969.
29. Andrew, M. E., A. M. Churilla, T. R. Malek, V. L. Braciale, and T. J. Braciale. 1985. Activation of virus specific CTL clones: antigen-dependent regulation of interleukin-2 receptor expression. J. Immunol. 134: 920-925.
30. + T lymphocyte responses. Nat. Immunol. 4: 361-365.
31. Adler, S. H., E. Chiffoleau, L. Xu, N. M. Dalton, J. M. Burg, A. D. Wells, M. S. Wolfe, L. A. Turka, and W. S. Pear. 2003. Notch signaling augments T cell responsiveness by enhancing CD25 expression. J. Immunol. 171: 2896-2903.
32. + T cell interactions in IFN-γ and IL-4 responses to viral infections: requirements for IL-2. J. Immunol. 160: 5007-5017.
33. van der Merwe, P. A., and S. J. Davis. 2003. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21: 659-684.
34. Lohr, J., B. Knoechel, S. Jiang, A. H. Sharpe, and A. K. Abbas. 2003. The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nat. Immunol. 4: 664-669.
35. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
36. + regulatory T cells. J. Immunol. 171: 3348-3352.
37. +. J. Exp. Med. 201: 127-137.
38. Zheng, Y., C. N. Manzotti, M. Liu, F. Burke, K. I. Mead, and D. M. Sansom. 2004. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172: 2778-2784.
39. Nelson, B. H. 2004. IL-2, regulatory T cells, and tolerance. J. Immunol. 172: 3983-3988.
40. + T cell numbers. J. Immunol. 169: 4850-4860.
41. Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178.